Abstract:Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease marked by inflammatory cell infiltration and joint damage. The Chinese government has approved the prescription medication sinomenine (SIN), an effective anti-inflammation drug, for treating RA. This study evaluated the possible anti-inflammatory actions of SIN in RA based on bioinformatics analysis and experiments. Six microarray datasets were acquired from the gene expression omnibus (GEO) database. We used R software to identify differentially expressed genes (DEGs) and perform function evaluations. The CIBERSORT was used to calculate the abundance of 22 infiltrating immune cells. The weighted gene co-expression network analysis (WGCNA) was used to discover genes associated with M1 macrophages. Four public datasets were used to predict the genes of SIN. Following that, function enrichment analysis for hub genes was performed. The cytoHubba and least absolute shrinkage and selection operator (LASSO) were employed to select hub genes, and their diagnostic effectiveness was predicted using the receiver operator characteristic (ROC) curve. Molecular docking was undertaken to confirm the affinity between the SIN and hub gene. Furthermore, the therapeutic efficacy of SIN was validated in LPS-induced RAW264.7 cells line using Western blot and Enzyme-linked immunosorbent assay (ELISA). The matrix metalloproteinase 9 (MMP9) was identified as the hub M1 macrophages-related biomarker in RA using bioinformatic analysis and molecular docking. Our study indicated that MMP9 took part in IL-17 and TNF signaling pathways. Furthermore, we found that SIN suppresses the MMP9 protein overexpression and pro-inflammatory cytokines, including tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in the LPS-induced RAW264.7 cell line. In conclusion, our work sheds new light on the pathophysiology of RA and identifies MMP9 as a possible RA key gene. In conclusion, the above findings demonstrate that SIN, from an emerging research perspective, might be a potential cost-effective anti-inflammatory medication for treating RA.

Microfluidics assisted synthesis and bioevaluation of sinomenine derivatives as antiinflammatory agents.

Synthesis and biological evaluation of novel sinomenine derivatives as anti-inflammatory agents.

Anti-inflammatory Effects of Novel Sinomenine Derivatives.

Multifunctional nanoparticles of sinomenine hydrochloride for treat-to-target therapy of rheumatoid arthritis via modulation of proinflammatory cytokines

Design, Synthesis and Molecular Docking Studies of Sinomenine Derivatives

Pharmacological mechanisms of sinomenine in anti-inflammatory immunity and osteoprotection in rheumatoid arthritis: A systematic review

Metabolic mechanism and anti-inflammation effects of sinomenine and its major metabolites N-demethylsinomenine and sinomenine-N-oxide

Synthesis of Sinomenine's Derivatives and Their Analgesic and Anti-Inflammatory Quantitative Structure-Activity Relationships

Advances in Anti-Inflammatory and Immunoregulatory Mechanisms of Sinomenine

Sinomenine Inhibits the Inflammatory Responses of Human Fibroblast-Like Synoviocytes Via the TLR4/MyD88/NF-κB Signaling Pathway in Rheumatoid Arthritis.

The Anti-Angiogenic Effect of Sinomenine.

Biocatalyzed cross-coupling of sinomenine and guaiacol by Antrodiella semisupina.

Rapid Characterization of the Potential Active of Sinomenine in Rats by Ultra‐High‐Performance Liquid Chromatography‐Quadrupole‐Exactive Orbitrap Mass Spectrometry and Molecular Docking

[Immunopharmacological Action of Sinomenine, an Alkaloid Isolated from Sinomenium Acutum, and Its Mechanism of Action in Treating Rheumatoid Arthritis].

Reducing Anaphylaxis Reactions and Enhancing Antiarthritic Effects of Folate-Conjugated Sinomenine-Loaded Human Serum Albumin Nanoparticles in Experimental Inflammation and Arthritis

Sinomenine Alleviates Rheumatoid Arthritis by Suppressing the PI3K-Akt Signaling Pathway, as Demonstrated Through Network Pharmacology, Molecular Docking, and Experimental Validation

Sinomenine treats rheumatoid arthritis by inhibiting MMP9 and inflammatory cytokines expression: bioinformatics analysis and experimental validation

Research, Development and Pharmacological Activity of Sinomenine and Its Derivatives

Graphene oxide quantum dots-loaded sinomenine hydrochloride nanocomplexes for effective treatment of rheumatoid arthritis via inducing macrophage repolarization and arresting abnormal proliferation of fibroblast-like synoviocytes

Regio-controlled Synthesis of Unsymmetrical Pyrazine-Fused Sinomenine Derivatives and Discriminate Substitution Effects on TNF-α Inhibitory Activity

Sinomenine Derivatives with Embedment of Nitrogen-Containing Heterocycles Exhibiting Potent TNF-αinhibitory Activity